JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹195 Cr | ₹164 Cr | ₹141 Cr | ₹143 Cr | ₹120 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹195 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹141 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹120 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹195 Cr | 18.51 | |
| Mar2024 | ₹164 Cr | 16.21 | |
| Mar2023 | ₹141 Cr | -0.84 | |
| Mar2022 | ₹143 Cr | 18.38 | |
| Mar2021 | ₹120 Cr | - | |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹495.9 Cr | -2.6% | 8.2% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -2.6% |
8.2% |
-2.1% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses